Implanon® failure and antiretroviral therapy [2]

Journal of Family Planning and Reproductive Health Care

Volumn 34, Issue 1, 2008, Pages 67-

  Barber, Tristan J ^a   Waters, Laura ^b  

^a CHELSEA AND WESTMINSTER HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^b IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EFAVIRENZ; ETHINYLESTRADIOL; ETONOGESTREL; GESTAGEN; LOPINAVIR PLUS RITONAVIR; NEVIRAPINE; 3 KETO DESOGESTREL; 3-KETO-DESOGESTREL; ANTIRETROVIRUS AGENT; CONTRACEPTIVE AGENT; DESOGESTREL; UNCLASSIFIED DRUG;

AMENORRHEA; DRUG EFFICACY; DRUG WITHDRAWAL; HEALTH SERVICE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; MENSTRUAL CYCLE; SEXUALLY TRANSMITTED DISEASE; TREATMENT FAILURE; DRUG IMPLANT; NOTE; UNITED KINGDOM;

ANTI-RETROVIRAL AGENTS; CONTRACEPTIVE AGENTS, FEMALE; DESOGESTREL; DRUG IMPLANTS; GREAT BRITAIN; HUMANS; TREATMENT FAILURE;

EID: 38349174515     PISSN: 14711893     EISSN: None     Source Type: Journal    
DOI: 10.1783/jfp.34.1.67b     Document Type: Letter

References (3)

1. Matiluko AA, Soundarajan L, Hogston P. Early contraceptive failure of Implanon® in an HIV-seropositive patient on triple antiretroviral therapy with zidovudine, lamivudine and efavirenz. J Fam Plann Reprod Health Care 2007; 33: 277-278.
2. Faculty of Family Planning and Reproductive Health Care Clinical Effectiveness Unit. FFPRHC Guidance (April 2005). Drug interactions with hormonal contraception. J Fam Plann Reprod Health Care 2005; 31: 139-151.
3. Faculty of Family Planning and Reproductive Health Care Clinical Effectiveness Unit. Members Enquiry Response (Enquiry Reference: 1072). May 2005. http://www.ffprhc.org.uk/admin/uploads/No1072.pdf [Accessed 20 October 2007].